Total | 402 (Male/female = 202/200) | ||||||
---|---|---|---|---|---|---|---|
Age | IDAF-4C+ | HT (%) | ExpFear | ExpIA | NExpFear | NExpIA | |
Max | 86 | 5.0 | 100 | 9.1 | 10.0 | 10.0 | 10.0 |
Min | 20 | 1.0 | 0 | 1.0 | 1.0 | 1.0 | 1.0 |
Median | 47 | 1.4 | 67 | 3.1 | 1.2 | 4.3 | 1.8 |
IQR | 27 | 1.0 | 25 | 3.0 | 1.8 | 3.8 | 3.0 |
Mean | 47 | 1.8 | 67 | 3.6 | 2.2 | 4.5 | 2.8 |
SD | 16 | 0.9 | 20 | 2.0 | 1.8 | 2.4 | 2.4 |
Community | 201 (Male/female = 105/96) | ||||||
---|---|---|---|---|---|---|---|
Age | IDAF-4C+ | HT (%) | ExpFeara | ExpIAa | NExpFearb | NExpIAb | |
Max | 86 | 5.0 | 100 | 8.9 | 10.0 | 10.0 | 10.0 |
Min | 20 | 1.0 | 0 | 1.0 | 1.0 | 1.0 | 1.0 |
Median | 46 | 1.4 | 67 | 3.1 | 1.3 | 4.0 | 2.0 |
IQR | 30 | 1.0 | 29 | 2.9 | 1.9 | 3.7 | 3.2 |
Mean | 45 | 1.8 | 65 | 3.6 | 2.3 | 4.4 | 2.9 |
SD | 17 | 0.9 | 21 | 2.0 | 1.9 | 2.4 | 2.4 |
Clinical | 201 (Male/female = 97/104) | ||||||
---|---|---|---|---|---|---|---|
Age | IDAF-4C+ | HT (%) | ExpFear | ExpIA | NExpFearb | NExpIAb | |
Max | 86 | 5.0 | 100 | 9.1 | 9.1 | 10.0 | 10.0 |
Min | 20 | 1.0 | 8 | 1.0 | 1.0 | 1.0 | 1.0 |
Median | 48 | 1.4 | 67 | 3.1 | 1.1 | 4.5 | 1.6 |
IQR | 25 | 1.0 | 25 | 3.1 | 1.6 | 3.9 | 3.0 |
Mean | 49 | 1.7 | 68 | 3.6 | 2.1 | 4.7 | 2.7 |
SD | 16 | 0.9 | 18 | 2.1 | 1.7 | 2.4 | 2.3 |
Comparisonc | n.s | n.s | n.s | n.s | n.s | n.s | n.s |